The Medicare GLP-1 Bridge: Monitoring Matters for Access

Explore the Medicare GLP-1 Bridge initiative, emphasizing the importance of monitoring for effective patient care and health outcomes in chronic disease management.

Medicare's Coverage Expansion for Weight Loss Drugs: A Game Changer

Medicare expands coverage for GLP-1 weight loss drugs, improving access and driving economic changes. Learn how this initiative impacts healthcare access.

Elevance Health Challenges CMS on Medicare Advantage Star Ratings

Elevance Health's legal challenge against CMS could reshape Medicare Advantage Star Ratings and impact insurance bonus payments across the industry.

Medicare GLP-1 Bridge: New Coverage for Weight Loss Drugs

Discover the new Medicare GLP-1 Bridge program offering weight loss drug coverage for seniors, making healthcare more affordable and accessible.

Improving Seniors' Timely Access to Care Act - Transparency in Medicare Advantage

The Improving Seniors' Timely Access to Care Act enhances transparency in Medicare Advantage, aiming to reduce prior authorization delays. Act now to support timely care for seniors.

Medicare GLP-1 Bridge Initiative: Affordable Weight-Loss Medications

Discover the Medicare GLP-1 Bridge initiative that offers reduced-cost access to weight-loss medications. A necessary step for better healthcare access.

Medicare Cost Cap Act: Protecting Seniors from Unlimited Expenses

Discover the Medicare Cost Cap Act aimed at limiting seniors' out-of-pocket expenses, enhancing financial security and aligning Medicare with modern health insurance models.

New Medicare Regulation Aims to Cut Drug Prices for Hospitals

The new Medicare regulation aims to reduce drug costs for hospitals, predicting $1.1 billion in savings for beneficiaries. Learn more about this significant change.

CMS Proposes Revisions to Medicare Payment Policies by 2027

CMS proposes crucial updates to Medicare payment policies for hospitals and home health agencies, ensuring compliance and enhancing service access.

New HHS Rule Seeks to Cut Drug Prices for Medicare Beneficiaries

The new HHS rule aims to cut drug prices for Medicare beneficiaries, targeting cost savings for hospitals in the 340B program while addressing billing concerns.